MANE Strengthens Innovation Capabilities with Acquisition of ChemoSensoryx Biosciences
In a major move to bolster its scientific leadership, MANE has successfully acquired ChemoSensoryx Biosciences, a pioneering Belgian biotech firm. ChemoSensoryx is globally recognized for its advanced research into the molecular mechanisms of chemosensory perception, specifically targeting olfactory, gustatory, and trigeminal receptors.
This acquisition integrates ChemoSensoryx’s cutting-edge technology platform for receptor-based screening and predictive modelling into MANE’s ecosystem. The synergy will deepen the scientific understanding of how complex aromas and tastes trigger physiological and emotional responses in consumers.
By merging MANE’s industrial expertise with ChemoSensoryx’s molecular insights, the company aims to deliver unprecedented precision in flavor and fragrance design. This research focuses on four key sensory pillars:
The integration of ChemoSensoryx Biosciences reinforces MANE’s commitment to providing global expertise that is constantly evolving. The combined research capabilities will facilitate:
- High-throughput screening of new aromatic molecules using receptor-based models.
- Predictive modelling to forecast consumer sensory preferences with scientific accuracy.
- Development of clean-label taste modulators to reduce sugar and salt without compromising experience.
- Strategic design of functional fragrances for the health and wellness sector.
Ultimately, this acquisition is about creating unique sensory experiences that consumers love. By mastering the molecular interface between chemistry and biology, MANE continues to deliver successful and lasting products for the global market.
